72.11.Z - Scientific research and development activities
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
82.92.Z - Packaging activities
82.99.Z - Other business support activities, not elsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 312,6 | 285,4 | 476,4 | 66,9 |
Gross profit (loss) | -82,6 | -336 | -389,2 | -15,8 |
Net profit (loss) | -82,6 | -336 | -389,2 | -15,8 |
Cash | 60,9 | 17,7 | 17,9 | 1 |
Net income from sale | 161,7 | 49,6 | 66,8 | 34,7 |
Liabilities and provisions for liabilities | 77,9 | 96,7 | 205,6 | 112,7 |
Short time liabilities | 67,1 | 78,1 | 183,7 | 135,3 |
Equity capital | 234,7 | 188,8 | 270,8 | 43,4 |
Working assets | 159,9 | 99,3 | 246,4 | 148,1 |
Operating profit (EBIT) | -78,7 | -335,5 | -388,4 | -15,8 |
% | % | % | p.p. | |
Equity capital to total assets | 75,1 | 66,1 | 56,8 | -9,3 |
Gross profit margin | -51 | -677,1 | -582,4 | 94,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 151 | 574 | 1003 | 429 |
Current financial liquidity indicator | 2.073138475418091 | 1.0480618476867676 | 1.2081072330474854 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane